Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial

被引：0
|
作者：
Favi, E. [1 ]
Silvestrini, N. [1 ]
Spagnoletti, G. [1 ]
Castagneto, M. [1 ]
Citterio, F. [1 ]
机构：
[1] Catholic Univ, Rome, Italy
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
388
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [31] Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
    Haynes, R.
    Harden, P.
    Landray, M.
    Baigent, C.
    Friend, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 155 - 155
  • [32] Long-term evaluation of basiliximab induction therapy in live donor kidney transplantation: A retrospective analysis
    Sheashaa, Hussein
    Fouda, Mohamed Ashraf
    Bakr, Mohamed Adel
    Sobh, Mohamed
    Ismail, Amany
    Ghoneim, Mohamed
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 266 - 266
  • [33] Induction Therapy with Rabbit Antithymocyte Globulin (rATG, Thymoglobulin®) vs Basiliximab After Kidney Transplantation: A Health Economic Analysis from a German Perspective.
    Cremaschi, L.
    Thissen, R.
    Benzing, T.
    Wiesener, M.
    Zink, N.
    Paivanas, T.
    Reitan, J.
    Gallagher, M.
    Thaiss, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 282 - 282
  • [34] Basiliximab induction therapy for live donor kidney transplantation: a long-term follow-up of prospective randomized controlled study
    Hussein A. Sheashaa
    Mohamed A. Bakr
    Amani M. Ismail
    Khaled M. Mahmoud
    Mohamed A. Sobh
    Mohamed A. Ghoneim
    Clinical and Experimental Nephrology, 2008, 12 : 376 - 381
  • [35] Basiliximab induction therapy for live donor kidney transplantation: a long-term follow-up of prospective randomized controlled study
    Sheashaa, Hussein A.
    Bakr, Mohamed A.
    Ismail, Amani M.
    Mahmoud, Khaled M.
    Sobh, Mohamed A.
    Ghoneim, Mohamed A.
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2008, 12 (05) : 376 - 381
  • [36] COMPARISON OF TWO DOSAGES OF THYMOGLOBULIN USED FOR INDUCTION IN DECEASED DONOR KIDNEY TRANSPLANTATION
    Lee, Dongyeol
    Lee, Jin Ho
    Kim, Seong-Min
    Oh, Joon-Seok
    Sin, Yong-Hun
    Kim, Joong-Kyung
    TRANSPLANT INTERNATIONAL, 2017, 30 : 483 - 483
  • [37] Basiliximab vs. Low-Dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients: Prospective Randomized Study in Southeastern Mexico.
    Martinez-Mier, G.
    Moreno-Ley, P. I.
    Budar-Fernandez, L. F.
    Mendez-Lopez, M. T.
    Barrera-Amoros, D. A.
    De la Paz-Roman, M.
    Jimenez-Lopez, L. A.
    Aguilar-Sandoval, E. G.
    Allende-Castellanos, C. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 822 - 823
  • [38] Basiliximab or Antithymocyte Globulin for Induction Therapy in Kidney Transplantation: A Meta-analysis
    Liu, Y.
    Zhou, P.
    Han, M.
    Xue, C-B
    Hu, X-P
    Li, C.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (05) : 1667 - 1670
  • [39] Basiliximab Versus Steroids in Double Therapy Immunosuppression in Liver Transplantation: A Prospective Randomized Clinical Trial
    Lupo, Luigi
    Panzera, Piercarmine
    Tandoi, Francesco
    Carbotta, Giuseppe
    Giannelli, Gianluigi
    Santantonio, Teresa
    Rendina, Maria
    Gentile, Antonietta
    Memeo, Vincenzo
    TRANSPLANTATION, 2008, 86 (07) : 925 - 931
  • [40] Outcomes of Thymoglobulin vs. Basiliximab Induction in Simultaneous Heart Kidney Transplant: A Single-Center Experience
    Bhargava, Juhi
    McGill, Rita L.
    Krishnamoorthy, Sambhavi
    Josephson, Michelle A.
    Kyeso, Yousuf
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 553 - 553
12345